2Athyros VG,Papageorgiou AA,Elisaf M, et al . Statins and renal function in patients with diabetes mellitus[J]. Curr Med Res Opin ,2003,19(7) :615-617.
3Khalid Almuti, Rola Rimawi, Daniel Spevack, et al . Effects of statins beyond lipid lowering: potential for clinical benefits [J]. Int J Cardiol ,2006,109(1):7-15.
6Chini EN,Chini C, Bolliger C, et al . Cytoprotective effects of adrenomedullin in glomcrular cell injury:central role of cAMP signaling pathway[J]. Kidney Int , 1997,52 : 917-925.
7Chen HC, Guh JY. Pravastatin suppress superoxide and fibronectin production of glomerular mesangial cells induced by oxidized LDL and high glucose [J]. Atherosclerosis , 2002, 160:141-146.
8Banes-Bereell AK, Shaw S, Ma G, et al . Effect of simvastatin on high glucose and angiotensin Ⅱ-induced activation of the JAK/STAT pathway in mesangial cells[J]. Am J Physiol Renal Physiol ,2006,291(1) :F116-121.
9Tsunekawa T, Kano H, Hayahi T, et al . Cerivastatin, a hydroxymethylglutaryl coenzyme A reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days[J]. Circulation ,2001,104:376-379.
10Economides PA, Caselli A, Tiani E, et al . The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes[J]. Clin Endocrinol Metablisrn , 2004,89 (2):740-747.
8[1]Usui H,Shikata K,Matsuda M,et al.HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats[J].Nephrol Dial Transplant,2003,18(2):265-272.
9[2]Ota T,Takamura T,Ando H,et al.Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model[J].Diabetologia,2003,46(6):843-851.
10[3]Nogaki F,Muso E,Yashiro M,et al.Direct inhibitory effects of simvastatin on matrix accumulation in cultured murine mesangial cells[J].Kidney Int Suppl,1999,71:S198-201.
